Technical Analysis for GBIO - Generation Bio Co.

Grade Last Price % Change Price Change
D 2.96 -4.21% -0.13
GBIO closed down 4.21 percent on Monday, March 18, 2024, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Pocket Pivot Bullish Swing Setup -4.21%
Wide Bands Range Expansion -4.21%
Hammer Candlestick Bullish -0.34%
NR7 Range Contraction -0.34%
Wide Bands Range Expansion -0.34%
Down 3 Days in a Row Weakness -0.34%
Down 4 Days in a Row Weakness -0.34%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 14 hours ago
Possible Inside Day about 14 hours ago
60 Minute Opening Range Breakdown about 16 hours ago
Down 3% about 16 hours ago
Fell Below 10 DMA about 17 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Generation Bio Co. Description

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery

Is GBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.98
52 Week Low 0.86
Average Volume 267,810
200-Day Moving Average 3.14
50-Day Moving Average 2.22
20-Day Moving Average 2.68
10-Day Moving Average 3.04
Average True Range 0.25
RSI (14) 60.00
ADX 49.62
+DI 31.47
-DI 10.36
Chandelier Exit (Long, 3 ATRs) 2.96
Chandelier Exit (Short, 3 ATRs) 2.69
Upper Bollinger Bands 3.54
Lower Bollinger Band 1.83
Percent B (%b) 0.66
BandWidth 63.65
MACD Line 0.28
MACD Signal Line 0.27
MACD Histogram 0.0037
Fundamentals Value
Market Cap 195.59 Million
Num Shares 66.1 Million
EPS -1.97
Price-to-Earnings (P/E) Ratio -1.50
Price-to-Sales 46.08
Price-to-Book 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.21
Resistance 3 (R3) 3.23 3.17 3.16
Resistance 2 (R2) 3.17 3.11 3.16 3.15
Resistance 1 (R1) 3.06 3.07 3.04 3.04 3.14
Pivot Point 3.01 3.01 2.99 2.99 3.01
Support 1 (S1) 2.90 2.94 2.87 2.88 2.78
Support 2 (S2) 2.84 2.90 2.83 2.77
Support 3 (S3) 2.74 2.84 2.76
Support 4 (S4) 2.71